A carregar...
Assessment of GSK1904529A as a promising anti-osteosarcoma agent
The insulin growth factor-I receptor (IGF1R) signaling is a key mechanism for osteosarcoma (OS) cell proliferation. GSK1904529A is a novel small molecule IGF1R kinase inhibitor. Its activity against OS cells was tested. In both established OS cell lines (Saos-2 and MG-63) and primary human OS cells,...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5564795/ https://ncbi.nlm.nih.gov/pubmed/28572530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17911 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|